Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

The agency also presented concerns that for the chronic migraine subgroup, there was no direct comparison with the current standard of treatment, botulinum toxin type A (Botox), so its superiority is

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition Allergan’s biggest product, Botox, is also facing tougher competition in the market from new migraine drugs and rivals in its medical aesthetics indications.

Strike three for Rova-T has AbbVie cutting its losses

Strike three for Rova-T has AbbVie cutting its losses In June it agreed to acquire Allergan in a  $63bn deal that adds $16bn in annual sales from products like wrinkle treatment Botox, diversifying its revenue stream.

AbbVie CEO Gonzalez defends Allergan takeover

AbbVie CEO Gonzalez defends Allergan takeover Richard Gonzalez. He downplayed the risks to Allergan’s Botox from branded rivals such as Evolus’ Jeuveau or biosimilars. ... reasons “it's highly unlikely that we would see a biosimilar against Botox for a long, long time, if ever.”.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn The company says the deal will significantly expand and diversify its revenue base with new therapeutic areas, including Allergan's leading medical aesthetics business, most notably Botox, which earned $3.7bn

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Tapping the potential of rare diseases: A journey into uncharted territory
...
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...

Infographics